European guidelines on cardiovascular disease prevention in clinical practice: executive summary by Ian Graham, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen,

Slides:

Advertisements

Similar presentations

Long-term compliance with beta-blockers, angiotensin- converting enzyme inhibitors, and statins after acute myocardial infarction by Gunnar H. Gislason,

Advertisements

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the.

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies by Lawrence de Koning,

Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary by Bernhard Maisch, Petar M. Seferović, Arsen D. Ristić, Raimund Erbel,

Guidelines for the diagnosis and treatment of pulmonary hypertension by, Nazzareno Galiè, Marius M. Hoeper, Marc Humbert, Adam Torbicki, Jean-Luc Vachiery,

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 by, John J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker, Angelo.

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode by Guillaume.

Guidelines for the prevention of cardiovascular disease in Ireland- the way forward 3 November 2010 European 4 th Joint Task Force Guidelines on CVD prevention.

The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study by Peter Barlis, Evelyn.

Guidelines on myocardial revascularization by,, William Wijns, Philippe Kolh, Nicolas Danchin, Carlo Di Mario, Volkmar Falk, Thierry Folliguet, Scot Garg,

Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation by Jesper Hjortnaes, Jonathan.

Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a.

High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease by Sven Plein, Sebastian Kozerke,

Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia by András Vereckei, Gábor Duray, Gábor Szénási, Gregory T.

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure by Markku S. Nieminen, Michael Böhm, Martin R. Cowie, Helmut.

Guidelines on the diagnosis and management of acute pulmonary embolism by, Adam Torbicki, Arnaud Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno.

How can you estimate simply the cardiovascular risk of your patients?

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)‏ by,, Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck.

Guidelines for the diagnosis and treatment of non-ST- segment elevation acute coronary syndromes by Jean-Pierre Bassand, Christian W. Hamm, Diego Ardissino,

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer.

Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with.

Platelet thrombin receptor antagonism and atherothrombosis by Dominick J. Angiolillo, Davide Capodanno, and Shinya Goto EHJ Volume 31(1):17-28 January.

Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay:

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator by Guiqing Yao, Nick Freemantle,

Guidelines for cardiac pacing and cardiac resynchronization therapy by Panos E. Vardas, Angelo Auricchio, Jean-Jacques Blanc, Jean-Claude Daubert, Helmut.

Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis by David C. Burgess, Michael.

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians by Willem J. Remme, John.

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction by Mortimer Korf-Klingebiel,

The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality by Jane Østergaard.

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary.

Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios.

Guidelines on the management of valvular heart disease by Alec Vahanian, Helmut Baumgartner, Jeroen Bax, Eric Butchart, Robert Dion, Gerasimos Filippatos,

Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair.

Hyperlipidaemiák Szollár Lajos Klinikai kórélettan Szeptember 28.

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty:

Electrocardiographic risk stratification in families with congenital long QT syndrome by Gerold Mönnig, Lars Eckardt, Horst Wedekind, Wilhelm Haverkamp,

Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population by Xavier Jouven, Peter.

Guidelines for the diagnosis and management of syncope (version 2009)‏ by,,,,,,,,,,,,, Angel Moya, Richard Sutton, Fabrizio Ammirati, Jean-Jacques Blanc,

Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation.

An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.

Acute effects of night-time noise exposure on blood pressure in populations living near airports by Alexandros S. Haralabidis, Konstantina Dimakopoulou,

The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease by Koon-Hou Mak, Deepak L. Bhatt,

Acute viral myocarditis by Robert Dennert, Harry J. Crijns, and Stephane Heymans EHJ Volume 29(17): August 25, 2008 Published on behalf of the.

Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled,

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 by , Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos,

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension.

Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis by Tuula A. Paajanen, Niku K.J. Oksala,

Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non- compaction, and septal defects by Lorenzo.

Dronedarone in patients with congestive heart failure: insights from ATHENA by Stefan H. Hohnloser, Harry J.G.M. Crijns, Martin van Eickels, Christophe.

EU Heart Group Brussels 2 October 2007 Fourth Joint European Societies’ Task Force on cardiovascular disease prevention in clinical practice Ian Graham,

Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction †

Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey by Philip Moons, Peter Engelfriet, Harald.

Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers by Leslee J. Shaw, Paolo Raggi, Tracy Q. Callister, and Daniel.

Presented by Slyter Nutrition Consulting Services.

Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions.

Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation.

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38.

High heart rate: a cardiovascular risk factor? by Stéphane Cook, Mario Togni, Marcus C. Schaub, Peter Wenaweser, and Otto M. Hess EHJ Volume 27(20):

Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease by Fabrizio Tomai, Flavio Ribichini,

Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study by Markus Juonala, Jorma.

Figure 1 Patient flow chart.

Figure 1 Flow chart of study selection.

O.L.Reuchlin gebruik van CT binnen de cardiogie

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Presentation transcript:

European guidelines on cardiovascular disease prevention in clinical practice: executive summary by Ian Graham, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph Herrmann-Lingen, Arno Hoes, Steve Humphries, Mike Knapton, Joep Perk, Silvia G. Priori, Kalevi Pyorala, Zeljko Reiner, Luis Ruilope, Susana Sans- Menendez, Wilma Scholte Op Reimer, Peter Weissberg, David Wood, John Yarnell, Jose Luis Zamorano, Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina, Alec Vahanian, John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, José Luis Zamorano, Irene Hellemans, Attila Altiner, Enzo Bonora, Paul N. Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J. Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F. Stalenhoef, Lale Tokgözoglu, Olov Wiklund, and Antonis Zampelas EHJ Volume (): August 28, 2007 © The European Society of Cardiology All rights reserved. For Permissions, please

The relationship of total cholesterol (TC):HDL cholesterol ratio to 10-year fatal CVD events in men and women aged 60 years with and without risk factors, based on a risk function derived from the SCORE project. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please

SCORE chart: 10-year risk of fatal CVD in populations at high CVD risk based on the following risk factors: age, gender, smoking, systolic blood pressure, and total cholesterol. © The European Society of Cardiology. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please

SCORE chart: 10-year risk of fatal CVD in populations at low CVD risk based on the following risk factors: age, gender, smoking, systolic blood pressure, and total cholesterol. © The European Society of Cardiology. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please

SCORE chart: 10-year risk of fatal CVD in populations at high CVD risk based on the following risk factors: age, gender, smoking, systolic blood pressure, and total cholesterol:HDL cholesterol ratio. © The European Society of Cardiology. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please

SCORE chart: 10-year risk of fatal CVD in populations at low CVD risk based on the following risk factors: age, gender, smoking, systolic blood pressure, and total cholesterol:HDL cholesterol ratio. © The European Society of Cardiology. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please

Relative risk chart. © The European Society of Cardiology. Ian Graham et al. Eur Heart J 2007;eurheartj.ehm316 © The European Society of Cardiology All rights reserved. For Permissions, please